glycated albumin, and some increase in fasting glucose, with modest impact of adjustment for sex, race center (white, Minneapolis, MN; black, Jackson, MS; white, Washington County, MD; black, Forsyth County, NC; white, Forsyth County, NC; as defined by the ARIC study design), BMI, and BMI 2 . At visit 5 among older adults (21 years later), increases with age were less evident for fasting glucose and HbA 1c compared with fructosamine and glycated albumin. Associations of age with HbA 1c , fructosamine, and glycated albumin at both visits persisted after further adjustment for fasting glucose.
The magnitude of the association we observed between HbA 1c and age, particularly in middle age (0.11% [1.2 mmol/mol] per 10 years of age), was similar to that in other studies (2) (3) (4) . Prior investigations adjusted for glucose to account for glycemia and attributed associations to nonglycemic hemoglobin-related factors. However, although HbA 1c and fasting glucose are highly related, they represent different glycemic constructs. We observed increases in HbA 1c , fructosamine, and glycated albumin independent of fasting glucose, suggesting that increases may be primarily glycemic or that putative nonglycemic factors may influence nonhemoglobin biomarkers.
The heterogeneity of dysglycemia across the life span may offer some explanation for the less consistent associations of age across the hyperglycemia biomarkers. Impaired insulin secretion is common in older age. As HbA 1c , fructosamine, and glycated albumin reflect postprandial glucose excursions in addition to fasting concentrations, their stronger associations with age as compared with fasting glucose could reflect that impaired glucose tolerance is more common than impaired fasting glucose in this population (5) .
Similar to previous investigations, our assessment is limited by its cross-sectional nature. Additionally, our analyses of older adults could be subject to selection bias. Study strengths include the communitybased sample, broad age range, and measurements at different time points in the life span.
In conclusion, we observed higher HbA 1c at older ages but also saw comparable associations for other (nonhemoglobinrelated) biomarkers of hyperglycemia. Our results provide some evidence that the age associations with HbA 1c , fasting glucose, fructosamine, and glycated albumin may reflect increases in the prevalence of hyperglycemia in aging. 
